2025-04-08 18:26:39
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Strides Pharma Science Ltd Q2FY22 consolidated loss at Rs. 162.55 crore
Posted On : 2021-11-10 16:40:47( TIMEZONE : IST )
Strides Pharma Science Limited has reported Consolidated financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 743.683 crores during the period ended September 30, 2021 as compared to Rs. 701.898 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. -162.559 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. -205.2 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. -18.12 for the period ended September 30, 2021 as compared to Rs. -22.88 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 743.683 crs | ₹701.898 crs |  5.95% |
| Net Profit | ₹ -162.559 crs | ₹-205.2 crs |  20.78% |
| EPS | ₹-18.12 | ₹-22.88 | 20.80% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 743.683 crores during the period ended September 30, 2021 as compared to Rs.806.429 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs. -162.559 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.80.945 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.-18.12 for the period ended September 30, 2021 as compared to Rs.9.03 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 743.683 crs | ₹806.429 crs |  -7.78% |
| Net Profit | ₹ -162.559 crs | ₹80.945 crs | -300.83% |
| EPS | ₹-18.12 | ₹9.03 | -300.66% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.1445.581 crores during the 6 Months period ended September 30, 2021 as compared to Rs.1600.531 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.-367.759 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.184.509 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.-40.99 for the 6 Months period ended September 30, 2021 as compared to Rs.20.58 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹1445.581 crs | ₹1600.531 crs | -9.68% |
| Net Profit | ₹-367.759 crs | ₹184.509 crs | -299.32% |
| EPS | ₹-40.99 | ₹20.58 | -299.17% |
Shares of Strides Pharma Science Limited was last trading in BSE at Rs. 551.05 as compared to the previous close of Rs. 549.20. The total number of shares traded during the day was 55915 in over 1849 trades.
The stock hit an intraday high of Rs. 559.75 and intraday low of 546.40. The net turnover during the day was Rs. 30922849.00.
